Evidence map›Paper›PMID 39095579›Full record

ArticleJournal of cancer research and clinical oncology2024

Pokemon inhibits Bim transcription to promote the proliferation, anti-anoikis, invasion, histological grade, and dukes stage of colorectal neoplasms.

Yan Wang, Huiling Zeng, Li Li, Jizhen Liu, Jiantao Lin, Yanhong Bie, Sen Wang, Xiaoguang Cheng, Bayaer Nashun, Yunhong Yao and 2 more

Abstract read
In one paragraph

Article in Journal of cancer research and clinical oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Yan Wang *Microbiology and Immunology Department, Guangdong Medical University, Dongguan, 523808, China.
Huiling Zeng *Microbiology and Immunology Department, Guangdong Medical University, Dongguan, 523808, China.
Li Li *Pathology Department, Huizhou Health Sciences Polytechnic, Huizhou, 516007, China.
Jizhen LiuAnimal Center of Guangdong Medical University, Guangdong Medical University, Dongguan, 523808, China.
Jiantao LinKey Laboratory of Molecular Diagnosis, Guangdong Medical University, Dongguan, 523808, China.
Yanhong BiePathology Department of The First Dongguan Affiliated Hospital, Guangdong Medical University, Dongguan, 523713, China.
Sen WangAnimal Center of Guangdong Medical University, Guangdong Medical University, Dongguan, 523808, China.
Xiaoguang ChengKey Laboratory of Molecular Diagnosis, Guangdong Medical University, Dongguan, 523808, China.
Bayaer NashunAnimal Center of Guangdong Medical University, Guangdong Medical University, Dongguan, 523808, China.
Yunhong YaoPathology Department of The First Dongguan Affiliated Hospital, Guangdong Medical University, Dongguan, 523713, China.
Xinrong HuPathology Department of The First Dongguan Affiliated Hospital, Guangdong Medical University, Dongguan, 523713, China. huxinrong@gdmu.edu.cn.
Yi ZhaoMicrobiology and Immunology Department, Guangdong Medical University, Dongguan, 523808, China. zhaoyicomnet@163.com.

Funding

Chinese Medicine Research Foundation of Guangdong Province 20161141Research Foundation Project of Guangdong Medical University Z2015004Research Foundation Project of Guangdong Medical University Z2017005Science and Technology Planning Project of Dongguan City 2016108101028Science and Technology Planning Project of Guangdong Province 2016A020215224The Natural Science Foundation of Guangdong Province 2015A030310046The Natural Science Foundation of Guangdong Province 2016A030313674
6 · The paper itself

Abstract

purposeThis study aims to determine whether Pokemon regulates Bim activity in colorectal carcinoma (CRC) carcinogenesis.

methodsClinical tissue samples were analyzed to detect the expression and clinicopathological significance of Pokemon and Bim in CRC. Proliferation, apoptosis, and invasion assays were conducted to identify the regulatory effect of Pokemon on Bim. The combined treatment effects of Pokemon knockdown and diamminedichloroplatinum (DDP) were also examined.

resultsImmunohistochemical analysis of 80 samples of colorectal epithelia (CRE), 80 cases of colorectal adenoma (CRA), and 160 of CRC samples revealed protein expression rates of 23.8%, 38.8%, and 70.6% for Pokemon, and 88.8%, 73.8%, and 31.9% for Bim, respectively. A significant negative correlation was observed between Pokemon and Bim expression across the CRE, CRA, and CRC lesion stages. In CRC, higher Pokemon and lower Bim expression correlated with higher histological grades, advanced Dukes stages, and increased cancer invasion. In both LoVo and HCT116 cells, overexpression of Pokemon significantly reduced Bim expression, leading to increased proliferation, resistance to anoikis, and cell invasion. Additionally, Pokemon overexpression significantly decreased DDP-induced Bim expression, reduction of anti-apoptosis and invasion, whereas Pokemon knockdown resulted in the opposite effects.

conclusionThese findings suggest that Pokemon inhibits Bim transcription, thereby promoting CRC proliferation, resistance to apoptosis, invasion, and advancing histological grade and Dukes staging. Pokemon knockdown enhances the therapeutic efficacy of DDP in the treatment of CRC.

Indexed as

Bcl-2-Like Protein 11Cell ProliferationColorectal NeoplasmsNeoplasm InvasivenessTranscription FactorsAgedAnoikisApoptosisCell Line, TumorDNA-Binding ProteinsFemaleGene Expression Regulation, NeoplasticHumansMaleMiddle AgedNeoplasm GradingBcl-2-Like Protein 11DNA-Binding ProteinsTranscription FactorsZBTB7A protein, humanAnoikisBimColorectal neoplasmsPokemon

Identifiers

PMID39095579
PMCPMC11297103

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.